ArcherDx Inc (ArcherDx), a subsidiary of Integrated DNA Technologies Inc, is a genomic analysis company. It offers next-generation sequencing (NGS) technology for detecting variants associated with cancer, auto-immune and other genetic diseases. The company’s research products include solid tumor research products, blood cancer research products, custom panels and clinical research products. ArcherDx solid tumor research panels enable biomarker detection from both liquid and tissue biopsies. The company’s blood cancer research panels detect various mutations in hematologic malignancies such as myeloid and lymphoid diseases targeted by next-generation sequencing (NGS). Its brands include Archer, Anchored Multiplex, FusionPlex and VariantPlex. ArcherDx is headquartered in Boulder, Colorado, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company ArcherDx Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
ArcherDx Inc Company Overview
ArcherDx Inc Company Snapshot
ArcherDx Inc Pipeline Products and Ongoing Clinical Trials Overview
ArcherDx Inc – Pipeline Analysis Overview
ArcherDx Inc - Key Facts
ArcherDx Inc - Major Products and Services
ArcherDx Inc Pipeline Products by Development Stage
ArcherDx Inc Pipeline Products Overview
AMP-Based Assay - Cancer
AMP-Based Assay - Cancer Product Overview
Companion Diagnostic Test - Diffuse Large B Cell Lymphoma
Companion Diagnostic Test - Diffuse Large B Cell Lymphoma Product Overview
FusionPlex Dx
FusionPlex Dx Product Overview
LiquidPlex Dx
LiquidPlex Dx Product Overview
NextSeq 550Dx System - Blood Cancer CDx Assay
NextSeq 550Dx System - Blood Cancer CDx Assay Product Overview
NextSeq 550Dx System - Minimal Residual Disease Assay
NextSeq 550Dx System - Minimal Residual Disease Assay Product Overview
NextSeq 550Dx System - Solid Tumor CDx Assay
NextSeq 550Dx System - Solid Tumor CDx Assay Product Overview
NGS-Based Companion Diagnostic Assay - Cancer
NGS-Based Companion Diagnostic Assay - Cancer Product Overview